|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...4142434445464748495051...110111» |
- Trial completion, Biopsy: Histopathological Diagnosis of Adenomyosis (clinicaltrials.gov) - Jul 22, 2015
P=N/A, N=200, Completed, Sponsor: Woman's Health University Hospital, Egypt
Recruiting --> Completed
- Votrient (pazopanib) / Novartis, BeiGene
Enrollment closed, Trial primary completion date: Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer (clinicaltrials.gov) - Jul 22, 2015
P1/2, N=57, Active, not recruiting, Sponsor: Priv.-Doz. Dr. med. Joachim Rom
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2012 --> Oct 2014
- Enrollment open: LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation (clinicaltrials.gov) - Jul 21, 2015
P=N/A, N=20, Recruiting, Sponsor: Rambam Health Care Campus
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2012 --> Oct 2014 Not yet recruiting --> Recruiting
- clomifene citrate / Generic mfg.
Trial primary completion date: Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Jul 21, 2015
P2/3, N=160, Recruiting, Sponsor: Benha University
Not yet recruiting --> Recruiting Trial primary completion date: May 2015 --> Aug 2015
- | Trial completion: AIN: A Trial of Radiofrequency Ablation for Anal Intraepithelial Neopplasia Using the HALO Ablation System (clinicaltrials.gov) - Jul 20, 2015
P=N/A, N=22, Completed, Sponsor: Medtronic - MITG
Trial primary completion date: May 2015 --> Aug 2015 Active, not recruiting --> Completed
- PF-06263507 / Pfizer
Enrollment change, Trial termination, Trial primary completion date, Metastases: A Study Of PF-06263507 In Patients With Advanced Solid Tumors (clinicaltrials.gov) - Jul 20, 2015
P1, N=26, Terminated, Sponsor: Pfizer
Active, not recruiting --> Completed N=36 --> 26 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Jun 2015; The study was terminated on June 23, 2015 due to the company's change in prioritization for the portfolio and is not due to any safety concerns.
- Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial primary completion date, Metastases: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Jul 17, 2015
P2, N=299, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
N=36 --> 26 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Jun 2015; The study was terminated on June 23, 2015 due to the company's change in prioritization for the portfolio and is not due to any safety concerns. Trial primary completion date: Aug 2015 --> Dec 2015
- ||||| MEDI0457 / AstraZeneca
New P2 trial, Combination therapy, Metastases: A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer (clinicaltrials.gov) - Jul 17, 2015
P2, N=126, Not yet recruiting, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
- Esmya (ulipristal acetate) / ASKA Pharma, HRA Pharma, Gedeon Richter, AbbVie
Trial primary completion date: A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas (clinicaltrials.gov) - Jul 16, 2015
P3, N=150, Recruiting, Sponsor: Watson Pharmaceuticals
Trial primary completion date: Aug 2015 --> Dec 2015 Trial primary completion date: Mar 2015 --> Jul 2015
- metformin / Generic mfg.
New trial: Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome (clinicaltrials.gov) - Jul 15, 2015
P0, N=166, Not yet recruiting, Sponsor: Ain Shams University
- New trial, Preclinical: In Vitro Follicle Activation (clinicaltrials.gov) - Jul 14, 2015
P=N/A, N=20, Recruiting, Sponsor: National Foundation for Fertility Research
- | carboplatin / Generic mfg., paclitaxel / Generic mfg., dasatinib / Generic mfg.
Enrollment closed, Metastases: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (clinicaltrials.gov) - Jul 14, 2015
P=N/A, N=15, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Mar 2015 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015 | Recruiting --> Active, not recruiting
- | cisplatin / Generic mfg., sorafenib / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Combination therapy: A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer (clinicaltrials.gov) - Jul 14, 2015
P1/2, N=13, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015 | Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=30 --> 13 | Trial primary completion date: Apr 2012 --> Sep 2010
- Enrollment open, Preclinical: Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF) (clinicaltrials.gov) - Jul 13, 2015
P=N/A, N=780, Recruiting, Sponsor: Vietnam National University
Active, not recruiting --> Completed | N=30 --> 13 | Trial primary completion date: Apr 2012 --> Sep 2010 Not yet recruiting --> Recruiting
- New trial: Effectiveness of Cognitive Behavioural Therapy and Physical Therapy for Provoked Vestibulodynia (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=20, Completed, Sponsor: Queen's University
- | pethidine / Samaritan
New P4 trial, Head-to-Head: A Non-inferiority Trial on Pain Relief During Oocyte Retrieval (clinicaltrials.gov) - Jul 10, 2015
P4, N=170, Not yet recruiting, Sponsor: Kwong Wah Hospital
- ||||||| Trial completion: Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding (clinicaltrials.gov) - Jul 10, 2015
P3, N=339, Completed, Sponsor: Bayer
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| Visanne (dienogest) / Mochida, Bayer
Trial completion, HEOR: DIVA: Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=3006, Completed, Sponsor: Bayer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Avastin (bevacizumab) / Roche
Trial primary completion date: BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer (clinicaltrials.gov) - Jul 10, 2015
P2, N=56, Recruiting, Sponsor: AA Secord
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> May 2016
- New trial: HRME-UH2: HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=200, Not yet recruiting, Sponsor: Barretos Cancer Hospital
- Elonva (corifollitropin alfa) / Organon
Enrollment status, Preclinical: Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients (clinicaltrials.gov) - Jul 9, 2015
P4, N=400, Recruiting, Sponsor: Vietnam National University
Trial primary completion date: Jun 2015 --> May 2016 Enrolling by invitation --> Recruiting
- Trial primary completion date: Factors Affecting the Prognosis of Patients With Endometrial Cancer (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=100, Recruiting, Sponsor: Far Eastern Memorial Hospital
Enrolling by invitation --> Recruiting Trial primary completion date: Dec 2014 --> Dec 2016
- Trial primary completion date: The Association of G9a Protein and the Outcome of Patients With Cervical Cancer (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=70, Recruiting, Sponsor: Far Eastern Memorial Hospital
Trial primary completion date: Dec 2014 --> Dec 2016 Trial primary completion date: Dec 2014 --> Dec 2016
- veliparib (ABT-888) / AbbVie
Trial primary completion date, BRCA Biomarker, PARP Biomarker: Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy (clinicaltrials.gov) - Jul 9, 2015
P1, N=120, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Dec 2014 --> Dec 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- Trial termination: SAT: Screen and Treat for Cervical Cancer Prevention (clinicaltrials.gov) - Jul 9, 2015
P3, N=7123, Terminated, Sponsor: Columbia University
Trial primary completion date: Jun 2015 --> Jun 2016 Active, not recruiting --> Terminated; PI left University
- triptorelin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: ENDOFIV: The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis (clinicaltrials.gov) - Jul 9, 2015
P4, N=200, Completed, Sponsor: Instituto de Investigacion Sanitaria La Fe
Active, not recruiting --> Terminated; PI left University Recruiting --> Completed | N=272 --> 200 | Trial primary completion date: Sep 2014 --> Mar 2015
- Trial completion, Trial primary completion date: Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=179, Completed, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Completed | N=272 --> 200 | Trial primary completion date: Sep 2014 --> Mar 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2015
- Trial completion: A Comparative Analysis of Arterial Blood Flow in Unexplained Infertility, Tubal Infertility and Fertile Groups (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=217, Completed, Sponsor: Suleymaniye Birth And Women's Health Education And Research Hospital
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2015 Enrolling by invitation --> Completed
- clomifene citrate / Generic mfg.
Trial primary completion date: DNAFRAG: The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Ghent
Enrolling by invitation --> Completed Trial primary completion date: Jun 2015 --> Dec 2015
- Trial primary completion date: Outcome of Women With Cervical Cancer (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=100, Recruiting, Sponsor: Far Eastern Memorial Hospital
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Jan 2015 --> Dec 2016
- New P3 trial: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer (clinicaltrials.gov) - Jul 8, 2015
P3, N=50, Not yet recruiting, Sponsor: The First People's Hospital of Changzhou
- Trial completion, Trial primary completion date: Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief (clinicaltrials.gov) - Jul 6, 2015
P=N/A, N=10, Completed, Sponsor: ProHealth Care, Inc
Trial primary completion date: Jan 2015 --> Dec 2016 Enrolling by invitation --> Completed | Trial primary completion date: Mar 2016 --> Jul 2015
- Norditropin (somatropin) / Novo Nordisk
Trial completion: Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (clinicaltrials.gov) - Jul 6, 2015
P=N/A, N=2016, Completed, Sponsor: Novo Nordisk A/S
Enrolling by invitation --> Completed | Trial primary completion date: Mar 2016 --> Jul 2015 Active, not recruiting --> Completed
- Preclinical, Trial primary completion date: Management of Abnormally Fertilized Zygotes? InVitro Correction of 3PN (clinicaltrials.gov) - Jul 6, 2015
P0, N=22, Enrolling by invitation, Sponsor: Ahmad Mustafa Mohamed Metwalley
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Sep 2015
- ||||| Zoptrex (zoptarelin doxorubicin) / AEterna Zentaris
Enrollment closed, Trial primary completion date, Metastases: ZoptEC: Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer (clinicaltrials.gov) - Jul 6, 2015
P3, N=500, Active, not recruiting, Sponsor: AEterna Zentaris
Trial primary completion date: Jun 2015 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- |||| Avastin (bevacizumab) / Roche
Trial completion, Trial primary completion date, Metastases: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors (clinicaltrials.gov) - Jul 6, 2015
P2, N=60, Completed, Sponsor: Dana-Farber Cancer Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed | Trial primary completion date: Sep 2013 --> Oct 2010
- | New P4 trial: Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure (clinicaltrials.gov) - Jul 2, 2015
P4, N=95, Completed, Sponsor: Dar El Teb Institute
- || New P3 trial: The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility (clinicaltrials.gov) - Jul 2, 2015
P3, N=130, Recruiting, Sponsor: Baskent University
- ||| Dotarem (gadoterate meglumine) / Guerbet
Trial completion, Enrollment change, Trial primary completion date: Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer (clinicaltrials.gov) - Jul 2, 2015
P=N/A, N=350, Completed, Sponsor: Universitaire Ziekenhuizen Leuven
Active, not recruiting --> Completed | Trial primary completion date: Sep 2013 --> Oct 2010 Recruiting --> Completed | N=200 --> 350 | Trial primary completion date: Nov 2015 --> Mar 2015
- Zymafos (palifosfamide) / Alaunos Therap
Enrollment change, Trial termination, Trial primary completion date: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors (clinicaltrials.gov) - Jul 2, 2015
P2, N=5, Terminated, Sponsor: Indiana University School of Medicine
Recruiting --> Completed | N=200 --> 350 | Trial primary completion date: Nov 2015 --> Mar 2015 N=20 --> 5 | Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Nov 2014; Due to Low Accrual
- New trial: Office Hysteroscopy and 3D Power Doppler Vaginal Ultrasound in Assessment of Postmenopausal Bleeding (clinicaltrials.gov) - Jul 2, 2015
P=N/A, N=100, Completed, Sponsor: Cairo University
- | HSV vaccine (GEN-003) / Genocea, Shionogi
Enrollment closed, Trial primary completion date: Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study (clinicaltrials.gov) - Jul 2, 2015
P2, N=45, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
N=20 --> 5 | Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Nov 2014; Due to Low Accrual Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2015 --> May 2016
- Preclinical, Trial primary completion date: Use of Predictive Model to Assist Patients Having an Embryo Transfer After IVF (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=276, Recruiting, Sponsor: Ottawa Fertility Centre
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2015 --> May 2016 Trial primary completion date: Feb 2014 --> Dec 2016
- || Enrollment change: Mirena or Conventional Medical Treatment for Menorrhagia (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=647, Completed, Sponsor: Bayer
Trial primary completion date: Feb 2014 --> Dec 2016 N=893 --> 647
- New trial, Head-to-Head, Biopsy: Hemostatic Procedure After Biopsy of the Cervix (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=160, Recruiting, Sponsor: Zydolab - Institute of Cytology and Immune Cytochemistry
- New P2 trial: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma (clinicaltrials.gov) - Jul 1, 2015
P2, N=50, Not yet recruiting, Sponsor: The First People's Hospital of Changzhou
- | Cetrotide (cetrorelix) / EMD Serono, Zorbtive (somatropin) / EMD Serono
Trial completion, Preclinical, Trial primary completion date: Growth Hormone for Poor Responders in in Vitro Fertilization (IVF) (clinicaltrials.gov) - Jul 1, 2015
P2, N=38, Completed, Sponsor: Ottawa Fertility Centre
N=893 --> 647 Recruiting --> Completed | Trial primary completion date: Sep 2011 --> May 2015
- || Enrollment closed: Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: University of Washington
Recruiting --> Completed | Trial primary completion date: Sep 2011 --> May 2015 Recruiting --> Active, not recruiting
- Trial primary completion date, Head-to-Head: SALPINGOVA: Effect of Salpingectomy During Conservative Hysterectomy (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=350, Recruiting, Sponsor: University Hospital, Tours
Recruiting --> Active, not recruiting Trial primary completion date: Nov 2015 --> Sep 2016
- Enrollment closed, Trial primary completion date: SOVS-CTG: Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=3500, Active, not recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Nov 2015 --> Sep 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015